Clementia Pharmaceuticals appoints Pierre Legault to its Board of Directors

– CANADA, Montreal – Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical-stage biopharmaceutical company innovating new treatments for people with ultra-rare bone disorders and other diseases, today announced the appointment of industry veteran, Pierre Legault, MBA, CA, CPA to the company’s board of directors.…